911.HK Stock Analysis
91
Uncovered
Qianhai Health Holdings Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.385
Dividend yield
1.28 %
Shares outstanding
1 694.45 B
Qianhai Health Holdings Ltd. engages in the sourcing and wholesaling of unprocessed American ginseng. The company employs 22 full-time employees The company went IPO on 2014-06-27. Along with subsidiaries, the Company operates its business through four segments. The Cultivated Ginseng segment is engaged in the purchasing and sale of cultivated American ginseng. The Wild Ginseng segment is engaged in the purchasing and sale of wild ginseng from the United States. The Ginseng Wine segment is engaged in the manufacturing and sale of ginseng wine. Its wine products include American wild ginseng brandy and American wild ginseng white spirit. The Others segment is engaged in the trading of other products, including dried cordyceps, dried cubilose, dried seafood and skin care products, among others.